Myocardial perfusion SPECT utility in predicting cardiovascular events among Indonesian diabetic patients

Open Cardiovascular Medicine Journal

Volumn 7, Issue 1, 2013, Pages 82-89

  Kasim, Manoefris ^a   Currie, Geoffrey M ^b,c   Tjahjono, Markus ^a   Siswanto, Bambang B ^a   Harimurti, Ganesja M ^a   Kiat, Hosen ^b,c,d  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b MACQUARIE UNIVERSITY   (Australia)

^c CHARLES STURT UNIVERSITY   (Australia)

^d Cardiac Health Institute   (Australia)

Author keywords

Cardiovascular event; Diabetes; Myocardial perfusion; Prognostic

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGE; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ETHNIC GROUP; EVENT FREE SURVIVAL; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; INCIDENCE; INDONESIAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SPECT SCANNER; SURVIVAL RATE;

EID: 84885347771     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401307010082     Document Type: Article

References (26)

1. Mihardja L, Delima, Manz HS, Ghani L, Soegondo S. Prevalence and determinants of diabetes mellitus and impaired glucose tolerance in Indonesia (a part of basic health research/Riskesdas). Acta Med Indones 2009; 41(4): 169-74.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
3. D'Souza A, Hussain M, Howarth FC, Woods NM, Bidasee K, Singh J. Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. Mol Cell Biochem 2009; 331: 89-116.
4. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105: 32-40.
5. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Eng J Med 1998; 339: 229-34.
6. Cohn PF. Silent myocardial ischemia. Ann Int Med 1988; 109: 312-7.
7. Dweck M, Campbell IW, Miller D and Francis CM. Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus. Br J Diabetes Vasc Dis 2009; 9: 110-6.
8. Dweck M, Miller D, Campbell IW, Francis CM. Mechanisms of silent myocardial ischaemia: with particular reference to diabetes mellitus. Br J Diabetes Vasc Dis 2009; 9: 99-102.
9. Prior JO, Monbaron D, Koehli M, Calcagni ML, Ruiz J, Bisch of Delaloye A. Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging 2005; 32[1]: 60-9.
10. WackersFJ, Young LH, Inzucchi SE, et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27(8): 1954-61.
11. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion singlephoton emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002; 90(8): 827-32.
12. 99mTc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitus. J Nucl Med 2005; 46: 1589-95.
13. Mohagheghie A, Ahmadabadi MN, Hedayat DK, Pourbehi MR, Assadi M. Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients. Nuklearmedizin 2011; 50[1]: 3-8.
14. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am CollCardiol 1995; 26(3): 639-47.
15. Schinkel AFL, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes. Diabetes Care 2002; 25: 1637-43.
16. Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 2004; 25: 543-50.
17. Germano G, Kiat H, Kavanagh PB, et al. Automatic Quantification of Ejection Fraction from Gated Myocardial Perfusion SPECT. J Nucl Med 1995; 36: 2138-47.
18. Shaw LJ and Iskandrian AE. Prognostic value of gated myocardial perfusion. J NuclCardiol 2004; 11: 171-85.
19. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999; 138: 1025-32.
20. Wiersma JJ, Verberne HJ, ten Holt WL, et al. Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris. J NuclCardiol 2009; 16: 524-32.
21. Adamu U, Knollmann D, Almutairi B, et al. Stress/rest myocardial perfusion scintigraphy in patients without significant coronary artery disease. J Nucl Cardiol 2010; 17: 38-44.
22. Venuraju SM, Yerramasu A and Lahiri A. Abnormal myocardial perfusion in the absence of anatomically significant coronary artery disease: Implications and clinical significance. J NuclCardiol 2010; 17: 8-12.
23. Su Y, Liu XM, Sun YM, Wang YY, Luan Y, Wu Y. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus. Am J Cardiol. 2008; 102: 497-8.
24. Alexanderson E, Valero MR, Martinez A, Calleja R, Lamothe PA, Sierra C, Rojas LG, et al. Endothelial dysfunction in recently diagnosed type 2 diabetic patients evaluated by PET. Mol Imaging Biol. 2009; 11: 1-5.
25. Amanullah AM, Berman DS, Erel J, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998; 82(6): 725-30.
26. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997; 80(4): 426-33.